Table 1. Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Size & CAGR: China VS Global, (US$ Million), 2019-2030

Table 2. Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Restraints

Table 3. Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Trends

Table 4. Chimeric Antigen Receptor (CAR)-T Cell Therapy Industry Policy

Table 5. Global Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue by Company (2019-2024) & (US$ million)

Table 6. Global Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue Market Share by Company (2019-2024)

Table 7. Global Chimeric Antigen Receptor (CAR)-T Cell Therapy Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 8. Global Chimeric Antigen Receptor (CAR)-T Cell Therapy Mergers & Acquisitions, Expansion Plans

Table 9. Global Chimeric Antigen Receptor (CAR)-T Cell Therapy Manufacturers Product Type

Table 10. China Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue by Company (2019-2024) & (US$ million)

Table 11. China Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue Market Share by Company (2019-2024)

Table 12. Global Key Players of Chimeric Antigen Receptor (CAR)-T Cell Therapy Upstream (Raw Materials)

Table 13. Global Chimeric Antigen Receptor (CAR)-T Cell Therapy Typical Customers

Table 14. Chimeric Antigen Receptor (CAR)-T Cell Therapy Typical Distributors

Table 15. By Type, Global Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue & CAGR, 2019 VS 2024 VS 2030, US$ Million

Table 16. By Application, Global Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue & CAGR, 2019 VS 2024 VS 2030, US$ Million

Table 17. By Region, Global Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Size, 2019 VS 2024 VS 2030, US$ Million

Table 18. By Region, Global Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue, 2019-2030, US$ Million

Table 19. By Country, Global Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue & CAGR，2019 VS 2024 VS 2030, US$ Million

Table 20. By Country, Global Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue, 2019-2030, US$ Million

Table 21. By Country, Global Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue Market Share, 2019-2030

Table 22. Autolus Therapeutics Company Information, Head Office, Market Area and Industry Position

Table 23. Autolus Therapeutics Company Profile and Main Business

Table 24. Autolus Therapeutics Chimeric Antigen Receptor (CAR)-T Cell Therapy Models, Specifications and Application

Table 25. Autolus Therapeutics Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue and Gross Margin, 2019-2024

Table 26. Autolus Therapeutics Recent Developments

Table 27. CARsgen Therapeutics Company Information, Head Office, Market Area and Industry Position

Table 28. CARsgen Therapeutics Company Profile and Main Business

Table 29. CARsgen Therapeutics Chimeric Antigen Receptor (CAR)-T Cell Therapy Models, Specifications and Application

Table 30. CARsgen Therapeutics Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue and Gross Margin, 2019-2024

Table 31. CARsgen Therapeutics Recent Developments

Table 32. Juno Therapeutics Company Information, Head Office, Market Area and Industry Position

Table 33. Juno Therapeutics Company Profile and Main Business

Table 34. Juno Therapeutics Chimeric Antigen Receptor (CAR)-T Cell Therapy Models, Specifications and Application

Table 35. Juno Therapeutics Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue and Gross Margin, 2019-2024

Table 36. Juno Therapeutics Recent Developments

Table 37. Sorrento Therapeutics Company Information, Head Office, Market Area and Industry Position

Table 38. Sorrento Therapeutics Company Profile and Main Business

Table 39. Sorrento Therapeutics Chimeric Antigen Receptor (CAR)-T Cell Therapy Models, Specifications and Application

Table 40. Sorrento Therapeutics Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue and Gross Margin, 2019-2024

Table 41. Sorrento Therapeutics Recent Developments

Table 42. bluebird bio Company Information, Head Office, Market Area and Industry Position

Table 43. bluebird bio Company Profile and Main Business

Table 44. bluebird bio Chimeric Antigen Receptor (CAR)-T Cell Therapy Models, Specifications and Application

Table 45. bluebird bio Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue and Gross Margin, 2019-2024

Table 46. bluebird bio Recent Developments

Table 47. CELGENE CORPORATION Company Information, Head Office, Market Area and Industry Position

Table 48. CELGENE CORPORATION Company Profile and Main Business

Table 49. CELGENE CORPORATION Chimeric Antigen Receptor (CAR)-T Cell Therapy Models, Specifications and Application

Table 50. CELGENE CORPORATION Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue and Gross Margin, 2019-2024

Table 51. CELGENE CORPORATION Recent Developments

Table 52. Eureka Therapeutics Company Information, Head Office, Market Area and Industry Position

Table 53. Eureka Therapeutics Company Profile and Main Business

Table 54. Eureka Therapeutics Chimeric Antigen Receptor (CAR)-T Cell Therapy Models, Specifications and Application

Table 55. Eureka Therapeutics Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue and Gross Margin, 2019-2024

Table 56. Eureka Therapeutics Recent Developments

Table 57. Avacta Life Sciences Company Information, Head Office, Market Area and Industry Position

Table 58. Avacta Life Sciences Company Profile and Main Business

Table 59. Avacta Life Sciences Chimeric Antigen Receptor (CAR)-T Cell Therapy Models, Specifications and Application

Table 60. Avacta Life Sciences Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue and Gross Margin, 2019-2024

Table 61. Avacta Life Sciences Recent Developments

Table 62. Calyxt Company Information, Head Office, Market Area and Industry Position

Table 63. Calyxt Company Profile and Main Business

Table 64. Calyxt Chimeric Antigen Receptor (CAR)-T Cell Therapy Models, Specifications and Application

Table 65. Calyxt Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue and Gross Margin, 2019-2024

Table 66. Calyxt Recent Developments

Table 67. Celyad Oncology SA Company Information, Head Office, Market Area and Industry Position

Table 68. Celyad Oncology SA Company Profile and Main Business

Table 69. Celyad Oncology SA Chimeric Antigen Receptor (CAR)-T Cell Therapy Models, Specifications and Application

Table 70. Celyad Oncology SA Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue and Gross Margin, 2019-2024

Table 71. Celyad Oncology SA Recent Developments

Table 72. Fortress Biotech Company Information, Head Office, Market Area and Industry Position

Table 73. Fortress Biotech Company Profile and Main Business

Table 74. Fortress Biotech Chimeric Antigen Receptor (CAR)-T Cell Therapy Models, Specifications and Application

Table 75. Fortress Biotech Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue and Gross Margin, 2019-2024

Table 76. Fortress Biotech Recent Developments

Table 77. IMMUNE THERAPEUTICS Company Information, Head Office, Market Area and Industry Position

Table 78. IMMUNE THERAPEUTICS Company Profile and Main Business

Table 79. IMMUNE THERAPEUTICS Chimeric Antigen Receptor (CAR)-T Cell Therapy Models, Specifications and Application

Table 80. IMMUNE THERAPEUTICS Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue and Gross Margin, 2019-2024

Table 81. IMMUNE THERAPEUTICS Recent Developments

Table 82. Gilead Sciences Company Information, Head Office, Market Area and Industry Position

Table 83. Gilead Sciences Company Profile and Main Business

Table 84. Gilead Sciences Chimeric Antigen Receptor (CAR)-T Cell Therapy Models, Specifications and Application

Table 85. Gilead Sciences Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue and Gross Margin, 2019-2024

Table 86. Gilead Sciences Recent Developments

Table 87. Novartis AG Company Information, Head Office, Market Area and Industry Position

Table 88. Novartis AG Company Profile and Main Business

Table 89. Novartis AG Chimeric Antigen Receptor (CAR)-T Cell Therapy Models, Specifications and Application

Table 90. Novartis AG Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue and Gross Margin, 2019-2024

Table 91. Novartis AG Recent Developments

Table 92. Alaunos Therapeutics Company Information, Head Office, Market Area and Industry Position

Table 93. Alaunos Therapeutics Company Profile and Main Business

Table 94. Alaunos Therapeutics Chimeric Antigen Receptor (CAR)-T Cell Therapy Models, Specifications and Application

Table 95. Alaunos Therapeutics Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue and Gross Margin, 2019-2024

Table 96. Alaunos Therapeutics Recent Developments

Table 97. Poseida Therapeutics Company Information, Head Office, Market Area and Industry Position

Table 98. Poseida Therapeutics Company Profile and Main Business

Table 99. Poseida Therapeutics Chimeric Antigen Receptor (CAR)-T Cell Therapy Models, Specifications and Application

Table 100. Poseida Therapeutics Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue and Gross Margin, 2019-2024

Table 101. Poseida Therapeutics Recent Developments

List of Figure

Figure 1. Chimeric Antigen Receptor (CAR)-T Cell Therapy Picture

Figure 2. Global Chimeric Antigen Receptor (CAR)-T Cell Therapy Industry Market Size and Forecast (US$ million) & (2019-2030)

Figure 3. China Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue and Forecast (US$ million) & (2019-2030)

Figure 4. 2019-2030 China Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Share of Global

Figure 5. Global Chimeric Antigen Receptor (CAR)-T Cell Therapy Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 6. Global Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2019-2024

Figure 7. China Chimeric Antigen Receptor (CAR)-T Cell Therapy Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 8. China Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2019-2024

Figure 9. Chimeric Antigen Receptor (CAR)-T Cell Therapy Industry Chain

Figure 10. Abecma

Figure 11. Breyanzi

Figure 12. Kymriah

Figure 13. Tecartus

Figure 14. Yescarta

Figure 15. Others

Figure 16. By Type, Global Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue, 2019-2030, US$ Million

Figure 17. By Type, Global Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue Market Share, 2019-2030

Figure 18. Hospital

Figure 19. Diagnostic Center

Figure 20. Other

Figure 21. By Application, Global Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue, 2019-2030, US$ Million

Figure 22. By Application, Global Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue Market Share, 2019-2030

Figure 23. By Region, Global Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue Market Share, 2019-2030

Figure 24. North America Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue & Forecasts, 2019-2030, US$ Million

Figure 25. By Country, North America Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue Market Share, 2019-2024

Figure 26. Europe Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue & Forecasts, 2019-2030, US$ Million

Figure 27. By Country, Europe Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue Market Share, 2019-2024

Figure 28. Asia Pacific Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue & Forecasts, 2019-2030, US$ Million

Figure 29. By Country/Region, Asia Pacific Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue Market Share, 2019-2024

Figure 30. South America Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue & Forecasts, 2019-2030, US$ Million

Figure 31. By Country, South America Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue Market Share, 2019-2024

Figure 32. Middle East & Africa Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue & Forecasts, 2019-2030, US$ Million

Figure 33. U.S. Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue, 2019-2030, (US$ Million)

Figure 34. By Company, U.S. Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Share, 2019-2024

Figure 35. By Type, U.S. Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue Market Share, 2022 VS 2029

Figure 36. By Application, U.S. Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue Market Share, 2022 VS 2029

Figure 37. Europe Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue, 2019-2030, (US$ Million)

Figure 38. By Company, Europe Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Share, 2019-2024

Figure 39. By Type, Europe Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue Market Share, 2022 VS 2029

Figure 40. By Application, Europe Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue Market Share, 2022 VS 2029

Figure 41. China Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue, 2019-2030, (US$ Million)

Figure 42. By Company, China Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Share, 2019-2024

Figure 43. By Type, China Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue Market Share, 2022 VS 2029

Figure 44. By Application, China Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue Market Share, 2022 VS 2029

Figure 45. Japan Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue, 2019-2030, (US$ Million)

Figure 46. By Company, Japan Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Share, 2019-2024

Figure 47. By Type, Japan Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue Market Share, 2022 VS 2029

Figure 48. By Application, Japan Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue Market Share, 2022 VS 2029

Figure 49. South Korea Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue, 2019-2030, (US$ Million)

Figure 50. By Company, South Korea Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Share, 2019-2024

Figure 51. By Type, South Korea Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue Market Share, 2022 VS 2029

Figure 52. By Application, South Korea Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue Market Share, 2022 VS 2029

Figure 53. Southeast Asia Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue, 2019-2030, (US$ Million)

Figure 54. By Company, Southeast Asia Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Share, 2019-2024

Figure 55. By Type, Southeast Asia Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue Market Share, 2022 VS 2029

Figure 56. By Application, Southeast Asia Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue Market Share, 2022 VS 2029

Figure 57. India Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue, 2019-2030, (US$ Million)

Figure 58. By Company, India Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Share, 2019-2024

Figure 59. By Type, India Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue Market Share, 2022 VS 2029

Figure 60. By Application, India Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue Market Share, 2022 VS 2029

Figure 61. Middle East & Asia Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue, 2019-2030, (US$ Million)

Figure 62. By Company, Middle East & Asia Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Share, 2019-2024

Figure 63. By Type, Middle East & Asia Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue Market Share, 2022 VS 2029

Figure 64. By Application, Middle East & Asia Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue Market Share, 2022 VS 2029

Figure 65. Research Methodology

Figure 66. Breakdown of Primary Interviews

Figure 67. Bottom-up Approaches

Figure 68. Top-down Approaches